For even the most new-to-the-program users, compiling a graph in Microsoft Excel is fairly intuitive. Excel offers a one-click option on its "Insert" menu to take data on a spreadsheet and render it ...

Exelixis, Inc. EXEL reported better-than-expected fourth-quarter results. EXEL recorded earnings of 55 cents per share, which beat the Zacks Consensus Estimate of 51 cents. The company registered ...

Exelixis’ (EXEL) lead drug, Cabometyx, a tyrosine kinase inhibitor (TKI), is one of the leading drugs for the treatment of renal cell carcinoma (RCC). The FDA approval for the label expansion of ...

It has been a mixed year so far for Exelixis, Inc. EXEL. Its lead drug, Cabometyx, approved for advanced renal cell carcinoma (RCC) and previously treated hepatocellular carcinoma (HCC), maintains ...